Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 291.50K | 277.40K | 353.10K | 276.80K | 254.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 291.50K | 277.40K | 353.10K | 276.80K | 254.30K |
| Cost of Revenue | 334.60K | 334.10K | 343.60K | 355.70K | 345.60K |
| Gross Profit | -43.00K | -56.60K | 9.60K | -78.90K | -91.50K |
| SG&A Expenses | 2.13M | 2.52M | 3.70M | 4.32M | 4.10M |
| Depreciation & Amortization | 107.40K | 105.40K | 101.40K | 93.80K | 90.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.97M | 3.52M | 4.80M | 5.47M | 5.28M |
| Operating Income | -2.68M | -3.24M | -4.45M | -5.19M | -5.02M |
| Income Before Tax | -2.92M | -3.61M | -4.42M | -4.92M | -5.91M |
| Income Tax Expenses | -- | -- | -- | -- | -31.40K |
| Earnings from Continuing Operations | -2.92 | -3.61 | -4.42 | -4.92 | -5.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.92M | -3.61M | -4.42M | -4.92M | -5.87M |
| EBIT | -2.68M | -3.24M | -4.45M | -5.19M | -5.02M |
| EBITDA | -2.57M | -3.14M | -4.35M | -5.10M | -4.93M |
| EPS Basic | -0.03 | -0.04 | -0.05 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
| EPS Diluted | -0.03 | -0.04 | -0.05 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 376.65M | 373.49M | 370.40M | 368.61M | 367.49M |
| Average Diluted Shares Outstanding | 376.65M | 373.49M | 370.40M | 368.61M | 367.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |